1. Introduction {#sec0005}
===============

The alteration of lipid metabolism is one of the major causes of complications arising from diabetes mellitus as it leads to increased risk of cardiovascular diseases [@bib0005]. The reversal of diabetic dyslipidaemia is thus a major strategy in diabetes treatment [@bib0010], [@bib0015].

In many countries of the world, much attention has been paid to find novel types of natural anti-diabetic drugs from various medicinal plants. These medicinal plants play important roles in the lives of rural people, particularly those in the remote parts of developing countries that have limited access to adequate health facilities. In addition, the effectiveness, limited side effects and relatively low costs of these medicinal plants make them to be widely prescribed even when their biologically active compounds are unknown [@bib0020].

Livingstone potato (*Plectranthus esculenthus* N.E.Br) which is known by its local name in Nigeria as *rizga*, is one of the widely cultivated minor root crops in the middle belt regions especially Kaduna and Plateau States of Nigeria for its finger like tubers [@bib0025]. The plant is also commonly found in Southern Africa, Malawi, Zimbabwe, Congo, Zambia and Asia [@bib0025].

Livingstone potato is used in ethnopharmacology in Africa in the treatment of digestive problems [@bib0025], stomach ache [@bib0030], pains [@bib0035] and cancer.

In our previous study [@bib0040], we described for the first time, the anti-diabetic potentials of this plant in streptozotocin induced diabetic rat models. However, there is no experimental evidence presently available in the literature with regard to its effect on serum glucose, glycated hemoglobin and lipid profiles of diabetic animals. Moreover, despite the usage of new diagnostic devices, strict glycemic targets, better treatment guidelines and increased awareness of the disease, baseline glycosylated hemoglobin has continued to remain relatively high in subjects diagnosed and treated for type 2 diabetes.

Since the alteration of lipid metabolism is one of the pathological basis for the development of diabetic complications and being that glycated hemoglobin is regarded as the best marker for glycemic control, this study was initiated to investigate the effect of livingstone potato on serum glucose, glycated hemoglobin and lipid metabolism of streptozotocin induced diabetes in rats.

2. Materials and methods {#sec0010}
========================

2.1. Plant materials {#sec0015}
--------------------

The fresh samples of livingstone potato (*Plectranthus esculenta*) were obtained at harvest from National Root Crops Research Institute (NRCRI), Umudike, Nigeria. They were identified by NRCRI, Umudike that has livingstone potato as a National Mandate as well as by a Taxonomist in Michael Okpara University of Agriculture, Umudike, Nigeria and deposited in their herbarium for authentication.

2.2. Chemicals {#sec0020}
--------------

Streptozotocin (STZ), [dl]{.smallcaps}-isocitric acid, β-nicotinamide adenine dinucleotide phosphate-sodium salt, triethanolamine, hydrochloride Gly--Gly, free base, [l]{.smallcaps}(−)malic acid, free acid, gallic acid, DPPH and standard quercetin used were products of Sigma and Aldrich Chemical Company, United Kingdom. The kits used for lipid profile assays were obtained from Randox Laboratories Limited (UK).

2.3. Processing of the plant materials {#sec0025}
--------------------------------------

The samples were properly washed, chopped and oven dried at 60 °C for 48 h. The dry samples were then processed to flour and incorporated into the standard rat feeds at 19.55% incorporation.

3. Animal experiments {#sec0030}
=====================

3.1. Selection of animals {#sec0035}
-------------------------

Thirty male albino rats of the wistar strain (140--208 g) obtained from the animal house of the Department of Biochemistry, University of Nigeria, Nsukka, Enugu State, Nigeria, were used for the study. The animals were kept in metabolic cages in the animal house of the Department of Biochemistry, Michael Okpara University of Agriculture, Umudike, Nigeria. The animals were acclimatized for two weeks to their diets prior to the commencement of the experiment and were maintained under a constant 12-h light and dark cycle and a room temperature of 27--30 °C. The National Institutes of Health Principles of Laboratory Animal Care [@bib0045] were observed.

3.2. Induction of diabetes {#sec0040}
--------------------------

After two weeks of acclimatization, freshly prepared solution of streptozotocin (0.1 g dissolved in 5 ml of freshly prepared sodium citrate buffer 0.1 M, pH 4.5) was injected intraperitoneally to 24 of the rats at a dosage of 65 mg/kg body weight at fasting state while the remaining 6 rats were taken as the non-diabetic groups. Blood was collected from the tail vein and the blood glucose concentration was analyzed prior to the commencement of the dietary feeding using a blood glucose meter (Double G glucometer, USA). The STZ-treated rats with fasting blood glucose levels \>200 mg/dl after twelve days of induction of STZ and evidence of glycosuria, were considered to be diabetic and used for the study.

3.3. Experimental procedure {#sec0045}
---------------------------

The STZ treated brats with stable diabetic condition were then divided into 2 subgroups (groups 2 and 3) comprising of six animals per group while the non-diabetic group formed the first group as follows:Group 1. Normal rats fed standard rat feeds (Non-diabetic control).Group 2. Diabetic control rats which also received standard rat feeds.Group 3. Diabetic rats fed livingstone potato incorporated feeds (test feed).

Their diets and water were both administered *ad libitum* for 28 days, after which the rats were stunned by blow, sacrificed and blood was drawn from their heart using 10 ml syringes and poured into heparin tubes for HbA~1C~ assays while the rest of the blood samples were collected in non-anti-coagulant tubes for serum assay of lipid profile and glucose.

3.4. Biochemical analysis {#sec0050}
-------------------------

The liver was removed, washed with ice-cold physiological saline immediately and stored at −20 °C until analyzed. Ten percent homogenate (w/v) of the liver was prepared in 150 mM KCl using a homogenizer at 4 °C [@bib0050] and centrifuged at 1000 × *g* for 5 min to remove cell debris. The supernatant was further centrifuged at 14,000 × *g* for 30 min at 4 °C and the supernatant was employed as the enzyme source for the assay of the malic enzyme and isocitrate dehydrogenase activities of the rats [@bib0055]. The specific activities of NADP linked malic enzyme (E.C. 1.1.1.40) and isocitrate dehydrogenase (EC 1.1.1.42) were determined using the methods of Geer et al. [@bib0060] and Bergmeyer [@bib0065]. Catalase was analyzed in the liver homogenates using the method of Sinha [@bib0070] and results were expressed as μmoles of H~2~O~2~ consumed/min/mg of wet liver tissue. The HbA~1C~ assay was carried out using the Biosysytems (Spain) diagnostic kit method as described by Karl et al. [@bib0075] and the principle was based on the quantification of the HbA~1C~ by a turbidimetric inhibition immunoassay after preparation of the hemolysate using tetradecyltrimethylammonium bromide as the detergent. The serum total triglycerides, cholesterol, glucose and HDL-cholesterol concentrations were analyzed using the Randox assay diagnostic kits as described by Tietz [@bib0080] and NCEP [@bib0085]. The serum total proteins were determined using Biosystems diagnostic kits as previously described [@bib0090].

The LDL-cholesterol and VLDL levels were calculated using the method of Friedewald [@bib0095]. The atherogenic index (AI) and coronary risk index (CRI) of the rats were calculated using the formula shown below as described by Omonkhua et al. [@bib0100]:

Atherogenic index (AI) = LDL-cholesterol/HDL-cholesterol; coronary risk index (CRI) = total cholesterol/HDL-cholesterol.

3.5. Preparation of the extract of the feeds for total phenolic assay {#sec0055}
---------------------------------------------------------------------

Six grams each of the flours of the test and standard rat feeds were soaked in 60 ml of water and left overnight. The mixtures were filtered (Whatman no. 1) and centrifuged at 3000 × *g* for 10 min for the assay of the phenolic contents of the flour samples.

3.6. Chemical analysis of the flours {#sec0060}
------------------------------------

The total phenolic contents of the extracts of the flour samples were determined using the Folin--Ciocalteu method as described by Singleton et al. [@bib0105]. Gallic acid was used as the standard and results were expressed in mg Gallic acid equivalents/100 g. The proximate and crude fiber contents of the flours of the test and standard rat feeds were determined using the methods of AOAC [@bib0110].

3.7. Rapid thin layer chromatrography (TLC) free radical scavenging screening {#sec0065}
-----------------------------------------------------------------------------

The TLC screening of the antioxidant activity of the methanolic extract of the test feed was determined using the DPPH method as proposed by Mensor et al. [@bib0115] with minor modifications. With the aid of a capillary tube, stock solutions (100 mg/ml) (instead of 1 mg/ml) of the extract were spotted on a silica gel thin layer chromatographic (TLC) plate and developed with a solvent system of ethanol: methanol (90:10). After development, the chromatograms were dried and sprayed with a 0.3 mM solution of the stable DPPH free radical. The plates were visualized for the presence of yellow spots and the degree of activity was determined qualitatively from observation of the yellow colour intensity. Yellow spot formed (within 30 min of spraying) against a purple background was taken as a positive result. Quercetin was used as the positive control for this assay.

3.8. Statistical analysis {#sec0070}
-------------------------

Data was subjected to analysis using the statistical package for social sciences (SPSS), version 15.0. Results were presented as the means ± standard deviations of three determinations. One way analysis of variance (ANOVA) was used for comparison of the means. Differences between means were considered to be significant at *P* \< 0.05 using the new Duncan multiple range test.

4. Results {#sec0075}
==========

The dose of the livingstone potato used in this study that produced the desired anti-diabetic action was 195.5 g/kg.

The serum glucose levels of the non-diabetic, diabetic control and diabetic rats given livingstone potato incorporated feeds were: 92.58 ± 3.97, 352.30 ± 4.88 and 165.50 ± 7.88 mg/dl, respectively ([Fig. 1](#fig0005){ref-type="fig"}). Intake of the livingstone potato incorporated feed by the diabetic rats of group 3, resulted in significant reduction (*P* \< 0.05) of their hyperglycemia compared with the diabetic control rats ([Fig. 1](#fig0005){ref-type="fig"}).Fig. 1Blood glucose level of rats. Values are the means + SD of three determinations. ^a--c^ Means with different superscripts differ significantly (*P* \< 0.05) in their glucose levels.

The percentage of glycated hemoglobin (HbA1c) of the rats, as shown in [Fig. 2](#fig0010){ref-type="fig"}, decreased in the following order: Diabetic control rats (9.57 ± 1.63%) \> Diabetic rats given livingstone potato incorporated feed (8.44 ± 0.85%) \> Non-diabetic group (6.03 ± 0.28%). The diabetic rats fed livingstone potato incorporated feed had significant reduction (*P* \< 0.05) of their HbA~1C~ levels compared with the diabetic control rats ([Fig. 2](#fig0010){ref-type="fig"}).Fig. 2Glycated hemoglobin status of rats. Values are the means ± SD of three determinations. ^a--c^ Means with different superscripts differ significantly (*P* \< 0.05) in the glycated hemoglobin contents. Biosystems reference values (%) 4--6.5 (non-diabetic); 6.0--7.0 (goal); 7.0--8.0 (good control); \>8.0 (action suggested).

The diabetic control rats had significant increases (*P* \< 0.05) of their serum cholesterol, triglycerides, LDL and VLDL levels but significant decreases of their serum HDL levels compared with the non diabetic rats ([Table 1](#tbl0005){ref-type="table"}).Table 1Serum lipid profile (mg/dl) of rats.GroupsCholTriVLDLHDLLDLGroup 189.15 ± 13.76^a^112.09 ± 23.33^a^22.42 ± 4.66^a^37.34 ± 6.10^b^29.39 ± 6.77^a^Group 2167.95 ± 17.95^b^183.23 ± 21.58^b^36.65 ± 4.32^b^22.01 ± 1.30^a^109.30 ± 12.72^c^Group 396.70 ± .26^a^127.23 ± 14.62^a^25.45 ± 2.92^a^33.50 ± 3.61^b^37.76 ± 1.27^b^[^1]

The diabetic rats fed the livingstone potato incorporated feed, recorded significant reduction (*P* \< 0.05) of their serum total cholesterol, triglycerides, VLDL and LDL but significant increase of their HDL levels compared with the diabetic control rats ([Table 1](#tbl0005){ref-type="table"}).

The diabetic control rats had significant increases (*P* \< 0.05) of their atherogenic and coronary risk indices compared with the non diabetic rats ([Table 2](#tbl0010){ref-type="table"}).Table 2Atherogenic index and coronary risk index of rats (units).GroupsAtherogenic indexCoronary risk indexGroup 10.78 ± 0.06^a^2.38 ± 0.13^a^Group 24.95 ± 0.29^c^7.61 ± 0.36^b^Group 31.14 ± 0.16^b^2.90 ± 0.15^a^[^2]

However, the diabetic rats given livingstone potato incorporated feed, recorded significant reduction (*P* \< 0.05) of their atherogenic and coronary risk indices compared with the diabetic control rats ([Table 2](#tbl0010){ref-type="table"}).

The hepatic malic enzyme (ME) activities of the non-diabetic, diabetic control and diabetic rats given livingstone potato incorporated feeds were 2.48 ± 0.4 units, 1.48 ± 0.16 units and 2.10 ± 0.08 units, respectively, ([Fig. 3](#fig0015){ref-type="fig"}) while the hepatic isocitrate dehydrogenase (IDH) activities of the non-diabetic, diabetic control and diabetic rats given livingstone potato incorporated feeds were 2.80 ± 0.43 units, 1.62 ± 0.29 units and 2.73 ± 0.53 units, respectively ([Fig. 3](#fig0015){ref-type="fig"}).Fig. 3Lipogenic enzyme activities of rats. Values are the means ± SD of three determinations. ^a--c^ Means with different superscripts for each parameter are significantly different (*P* \< 0.05): units definition: malic enzyme---μmol of pyruvate liberated/min/g protein; isocitrate dehydrogenase---μmol of α-KGT liberated/min/g protein.

There were significant reduction (*P* \< 0.05) of the hepatic malic enzyme and isocitrate dehydrogenase activities of the diabetic control rats compared with the non-diabetic rats ([Fig. 3](#fig0015){ref-type="fig"}).

However, there were significant increases (*P* \< 0.05) of the hepatic malic enzyme and isocitrate dehydrogenase activities of the diabetic rats given livingstone potato incorporated feeds compared with the diabetic control rats ([Fig. 3](#fig0015){ref-type="fig"}).

The diabetic control rats had significant reduction (*P* \< 0.05) of their hepatic catalase activities compared with the non-diabetic rats ([Table 3](#tbl0015){ref-type="table"}).Table 3Hepatic catalase activity of rats.GroupsCatalase (μmol of H~2~O~2~ consumed/min/mg of wet liver tissue)Non-diabetic82.40 ± 3.52^c^Diabetic control40.75 ± 4.77^a^Diabetic + livingstonepotato57.20 ± 3.97^b^[^3]

Intake of the livingstone potato incorporated feed by the diabetic rats of group 3 resulted in significant elevation (*P* \< 0.05) of their hepatic catalase activity compared with the diabetic control rats ([Table 3](#tbl0015){ref-type="table"}).

The body weights of the diabetic control rats were significantly reduced (*P* \< 0.05) compared with the non-diabetic rats while the body weights of the diabetic rats given the livingstone potato incorporated feed were significantly increased (*P* \< 0.05) compared with the diabetic control rats ([Table 4](#tbl0020){ref-type="table"}).Table 4Body weight of rats (g).GroupsInitial weightFinal weightGroup 1185.50 ± 4.95^ab^233.00 ± 4.24^c^Group 2156.50 ± 16.26^b^102.50 ± 7.78^a^Group 3207.00 ± 1.41^b^179.00 ± 1.41^b^[^4]

The feed intake of the diabetic control rats was not significantly different (*P* \> 0.05) from that of the non-diabetic rats by the last week of experimentation while the feed intake of the diabetic rats given the livingstone potato incorporated feed was significantly higher (*P* \< 0.05) than that of the diabetic control rats by the last week of experimentation ([Table 5](#tbl0025){ref-type="table"}).Table 5Feed intakes per rat (g/week).GroupsWeek 1Week 2Week 3Week 4Group 1118.22 ± 7.43^a^127.05 ± 8.97^b^122.00 ± 12.37^b^133.34 ± 1.32^a^Group 2117.07 ± 5.88^a^121.95 ± 9.11^b^119.60 ± 3.99^a^137.84 ± 5.77^a^Group 3119.56 ± 2.54^a^106.29 ± 5.75^a^140.24 ± 0.88^c^146.38 ± 4.33^b^[^5]

Proximate analysis of the livingstone potato incorporated and standard feeds showed that the standard rat feed contained 15.00 ± 0.78% protein, 7.24 ± 1.20% fat, 31.55 ± 2.62% carbohydrates with an energy value of 290.65 ± 4.77 kcal/100 g while the livingstone potato incorporated feed contained 40.10 ± 0.16% carbohydrates, 17.22 ± 0.40% protein, 22.16 ± 0.34% fat with an energy value of 428.70 ± 2.12 kcal/100 g.

Phytochemical and crude fiber analysis of the livingstone potato incorporated and standard rat feeds revealed that the livingstone potato incorporated feed contained 1.3 ± 0.2 mg gallic acid equivalent/g of sample and 8.51 ± 0.16% crude fiber while the standard rat feed contained 0.12 ± 0.04 mg gallic acid equivalent and 10% crude fiber ([Fig. 4](#fig0020){ref-type="fig"}).Fig. 4Phenolic and crude fiber composition of standard and livingstone potato incorporated feed. Values are the means ± SD of three determinations.

Antioxidant screening of the methanolic/ethanolic extract of the livingstone potato incorporated feed using rapid thin layer chromatographic assay indicated that it possessed strong antioxidant activity comparable to standard quercetin ([Table 6](#tbl0030){ref-type="table"}).Table 6Free radical scavenging activities of the methanolic/ethanolic extracts of livingstone potato incorporated feed using Rapid DPPH TLC screening.PlantsAntioxidant activityIntensity of spotLivingstone potatoStrong+++QuercetinStrong+++[^6]

5. Discussion {#sec0080}
=============

The STZ rat model of diabetes is one of the most commonly used models of human disease [@bib0120] because it mimics many of the complications of human diabetes.

The reduction of the serum glucose of the diabetic rats fed the test plant to the extent that was observed in this study is an indication of the ameliorating potentials of livingstone potato on hyperglycemia.

Glycated hemoglobin (HbA~1C~) is a product of the irreversible condensation of glucose with the N-terminal residue of the β-chain of hemoglobin A. The level of glycated hemoglobin is a useful and reliable tool for the assessment of glycemic control in diabetics as recommended by the International Diabetes Federation [@bib0125] as it reflects the average blood glucose concentration over the preceding 6--8 weeks [@bib0130], [@bib0135], [@bib0140], equivalent to the life time of the erythrocytes.

Several authors have reported the ameliorating actions of different anti-diabetic plants on the HbA~1C~ status of streptozotocin diabetic rat models in short term studies [@bib0145], [@bib0150], [@bib0155].

Although the duration of this study was short, the significant reduction of the HbA~1C~ levels of the diabetic rats fed the test feed underscores the importance of livingstone potato in the dietary management of diabetes and its complications since reduction of glycated hemoglobin is known to decrease diabetic complications [@bib0160].

Hypercholesterolemia and hyper-triglyceridemia are recognized complications of diabetes mellitus [@bib0165], [@bib0170] resulting from alterations in lipid metabolism characterized by elevated levels of cholesterol, triglycerides, VLDL and LDL and this could account for the elevated levels of cholesterol, triglycerides, VLDL and LDL in the diabetic untreated rats.

Studies have shown that atherogenic index is a good predictor of cardiovascular disease risk as well as efficient monitor of the effectiveness of lipid-lowering therapies since the LDL/HDL ratio has been considered more prognostic than LDL or HDL alone [@bib0170].

The significant reduction of the serum total cholesterol, VLDL, triglycerides, LDL-cholesterol, atherogenic and coronary risk indices together with the concomitant significant increase in the HDL levels of the diabetic rats fed the test feed, indicate the anti-hyperlipidemic potentials of livingstone potato.

The triglyceride lowering property of livingstone potato as observed in this study could indirectly have contributed to its anti-hyperglycemic activity through the mechanism of the glucose-fatty acid cycle [@bib0175] which reports that increased supply of triglycerides could constitute a source of increased free fatty acid availability and oxidation that can impair insulin action, glucose metabolism and utilization, leading to the development of hyperglycemia. Therefore, reduction of triglycerides after feeding of livingstone potato incorporated feed would also facilitate glucose oxidation, utilization and subsequently reduction of hyperglycemia.

Malic enzyme catalyzes the oxidative decarboxylation of cytoplasmic malate [@bib0050], [@bib0130]. The reaction helps to transfer cytoplasmic oxaloacetate to the mitochondrion which is important in the TCA cycle for the formation of citrate with acetyl-CoA for generating malate which can feed the cytosolic gluconeogenic pathway [@bib0050], [@bib0180].

Isocitrate dehydrogenase catalyzes the oxidative decarboxylation of isocitrate to α ketoglutarate and requires either NAD^+^ or NADP^+^, producing NADH and NADPH, respectively [@bib0185]. It is another key regulatory enzyme in lipogenesis, which supplies the NADH from the extra mitochondrial space for the generation of NADPH through the activity of the malic enzyme.

During diabetes, lipogenesis is decreased while lipolysis is increased in the hepatic tissue which results from the underutilization of glucose resulting in increased lipolysis [@bib0190] and this explains the reduced hepatic levels of the lipogenic enzymes-ME and IDH in the diabetic control rats. Similar kinds of results were reported [@bib0130], [@bib0195]. This decrease to the extent that was observed in this study could lead to decreased generation of NADPH needed for the regeneration of glutathione and other reducing agents that are needed for the maintenance of tissue integrity and oxidative balance.

However, the increased hepatic ME and IDH activities of the diabetic rats fed livingstone potato incorporated feed indicates better utilization of glucose or energy yielding intermediates by the TCA cycle [@bib0190].

Results obtained in this study indicate that treatment of diabetics with livingstone potato increases the utilization of circulating glucose by the liver.

The loss of weight by the diabetic control rats despite increased feed intake is an indication of loss of tissue proteins that contribute to body weight while the increase in weight by the diabetic rats fed the livingstone potato incorporated feed is simple due to treatment of hyperglycemia.

The recommended daily allowance for fat in diabetic patients is 15--20% of the total calorie [@bib0200]. Crude fat provided about 22.16% of the total calories of the livingstone potato incorporated feed and 7.24% of the total calories of the standard rat feed. The implication is that while the fat content of the standard rat feed failed to meet the daily requirement, the fat content of the livingstone potato incorporated feed did.

Crude protein provided about 15% of the total calories of the standard rat feed and about 17.22% of the livingstone potato incorporated feed.

The recommended daily allowance for proteins in diabetic patients is 15--20% of the total calories [@bib0200]. Thus, the range of proteins in both the standard rat feed and the livingstone potato incorporated feed did meet with this requirement.

It is worth noting that despite containing large amount of proteins, consumption of the standard rat feeds by the diabetic control rats did not translate into weight gain which is a confirmation that the loss of weight by the diabetic control rats despite eating highly proteinous diet was as a result of uncontrolled hyperglycemia while the gain in weight after feeding of livingstone potato incorporated feed resulted from glycemic control [@bib0205].

Total carbohydrates provided approximately 40.1% of the total calories for the livingstone potato incorporated feed and 31.55% of the total calories for the standard rat feed. Values obtained for both feed samples were lower than the recommended daily allowance for carbohydrates (50--70% of total calories) in diabetics [@bib0200].

Energy value of a food measures its value to the body as a fuel. The test feed was observed to contain higher energy value than the standard rat feed.

Phenolics have received considerable attention because of their potential antioxidant activity and effects on carbohydrate metabolism involving the inhibition of α-glucosidase and α-amylase, the key enzymes responsible for digestion of dietary carbohydrates to glucose [@bib0210].

Another important action of polyphenols on cardiovascular system in diabetes is the regulation of lipid and lipoprotein metabolism with resultant improvement of dyslipidemia [@bib0215].

The higher phenolic content of the livingstone potato incorporated feed compared with the standard rat feed, could be one explanation for the higher anti-diabetic and anti-hyperlipidemic actions demonstrated by livingstone potato compared with the standard rat feed in this study.

Oxidative stress has recently been implicated in pancreatic β-cell dysfunction. Several reaction mechanisms are thought to be involved in the genesis of oxidative stress in both diabetic patients and diabetic animals and they include: glucose auto-oxidation, protein glycation, formation of advanced glycation products and the polyol pathway. The production of reactive oxygen species during these processes leads to tissue damage [@bib0220].

The decrease in the hepatic catalase activity of the diabetic control rats to the extent that was observed in this study could precipitate oxidative stress to the liver while the increased hepatic catalase activity of the diabetic rats fed the livingstone potato incorporated feed shows that intake of livingstone potato by diabetics could protect the liver from oxidative damage.

The strong antioxidant activity of the methanolic/ethanolic extract of the livingstone potato incorporated feed could be the explanation for the modulation of the hepatic antioxidant status of the diabetic rats fed the livingstone potato incorporated feed. Furthermore, this strong antioxidant activity could be attributed to the phenolic content of the livingstone potato incorporated feed.

Dietary fiber decreases the absorption of cholesterol from the gut in addition to delaying the digestion and conversion of starch to simple sugars, an important factor in the management of diabetes. Dietary fibred also functions in the protection against cardiovascular disease, colorectal cancer and obesity [@bib0225].

However, it was observed that the crude fiber contents of the standard rat feeds were higher than that of the livingstone potato incorporated feed.

It is therefore plausible to suggest that the hypoglycemic and anti-hyperlipidemic actions demonstrated by livingstone potato in this study could be directly related to its phenolic constituents.

6. Conclusion {#sec0085}
=============

Results obtained in this study, indicate the anti-hyperlipidemic potentials of livingstone potato. The significant reduction of the HbA~1C~ levels of the diabetic rats fed the livingstone potato incorporated feeds underscores the importance of livingstone potato in the dietary management of diabetes mellitus and its complications.
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[^1]: Values are means ± SD. ^a--c^ Means with different superscripts along each column are significantly different (*P* \< 0.05). Chol---cholesterol; Tri---triglyceride.

[^2]: Values are means ± SD. ^a--c^ Means with different superscripts along each column are significantly different (*P* \< 0.05). Units-ratio.

[^3]: ^a--c^ Values are the means ± SD of triplicate experiments. Means with different superscripts are significantly different (*P* \< 0.05).

[^4]: ^a--c^ Means with different superscripts along each column are significantly different (*P* \< 0.05).

[^5]: Values are means ± SD. ^a--c^ Means with different superscripts along each column are significantly different (*P* \< 0.05).

[^6]: The degree of antioxidant activity, determined qualitatively from the observation of the yellow colour intensity: strong (+++).
